The treatment interventions and targets of cancer cachexia research during the past decade: a systematic review of the literature.

IF 2.1 Q3 GASTROENTEROLOGY & HEPATOLOGY Annals of Gastroenterology Pub Date : 2025-01-01 Epub Date: 2024-10-20 DOI:10.20524/aog.2024.0918
Panagiotis Filis, Dimitrios Peschos, Yannis V Simos, Nikolaos Filis, Christianna Zachariou, Dimitrios Stagikas, Konstantinos I Tsamis
{"title":"The treatment interventions and targets of cancer cachexia research during the past decade: a systematic review of the literature.","authors":"Panagiotis Filis, Dimitrios Peschos, Yannis V Simos, Nikolaos Filis, Christianna Zachariou, Dimitrios Stagikas, Konstantinos I Tsamis","doi":"10.20524/aog.2024.0918","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Cachexia is a detrimental multifactorial syndrome that has been strongly associated with cancer. A growing body of data concerning its management is being generated from the ongoing advances of experimental cancer cachexia research. This study aimed to delineate the broad landscape of cancer cachexia research, by comprehensively presenting the treatment interventions and targets of cancer cachexia during the past decade.</p><p><strong>Methods: </strong>A systematic literature search was performed in Medline and Scopus databases from January to April 2023. Articles were considered eligible if they described any type of intervention in tumor-bearing rodents to study the effect on prevention or treatment of cancer cachexia. The corresponding signaling and metabolic pathways that were targeted by these interventions were documented.</p><p><strong>Results: </strong>A total of 271 articles were considered eligible for our study. Of these, 176 studies pertained to pharmaceutical interventions with 100 corresponding targets, 58 studies pertained to nutritional interventions with 60 corresponding targets, and 37 studies pertained to exercise interventions with 60 corresponding targets.</p><p><strong>Conclusions: </strong>The continuous evolution of cancer cachexia research has provided a plethora of disease targets and corresponding treatment interventions. Moving forward, the available management strategies should be refined and clinical research should efficiently capitalize on the robust experimental evidence.</p>","PeriodicalId":7978,"journal":{"name":"Annals of Gastroenterology","volume":"38 1","pages":"85-92"},"PeriodicalIF":2.1000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11724389/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Gastroenterology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20524/aog.2024.0918","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/20 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Cachexia is a detrimental multifactorial syndrome that has been strongly associated with cancer. A growing body of data concerning its management is being generated from the ongoing advances of experimental cancer cachexia research. This study aimed to delineate the broad landscape of cancer cachexia research, by comprehensively presenting the treatment interventions and targets of cancer cachexia during the past decade.

Methods: A systematic literature search was performed in Medline and Scopus databases from January to April 2023. Articles were considered eligible if they described any type of intervention in tumor-bearing rodents to study the effect on prevention or treatment of cancer cachexia. The corresponding signaling and metabolic pathways that were targeted by these interventions were documented.

Results: A total of 271 articles were considered eligible for our study. Of these, 176 studies pertained to pharmaceutical interventions with 100 corresponding targets, 58 studies pertained to nutritional interventions with 60 corresponding targets, and 37 studies pertained to exercise interventions with 60 corresponding targets.

Conclusions: The continuous evolution of cancer cachexia research has provided a plethora of disease targets and corresponding treatment interventions. Moving forward, the available management strategies should be refined and clinical research should efficiently capitalize on the robust experimental evidence.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
近十年来癌症恶病质研究的治疗干预和目标:文献系统综述。
背景:恶病质是一种有害的多因素综合征,与癌症密切相关。随着实验性癌症恶病质研究的不断进展,有关其管理的数据越来越多。本研究旨在通过全面介绍过去十年来癌症恶病质的治疗干预措施和靶点,描绘癌症恶病质研究的广阔前景。方法:系统检索Medline和Scopus数据库,检索时间为2023年1 - 4月。如果文章描述了任何类型的干预,以研究对癌症恶病质的预防或治疗效果,则被认为是合格的。记录了这些干预措施所针对的相应的信号传导和代谢途径。结果:共有271篇文章被认为符合我们的研究。其中,176项研究涉及药物干预,有100个相应的目标;58项研究涉及营养干预,有60个相应的目标;37项研究涉及运动干预,有60个相应的目标。结论:癌症恶病质研究的不断发展提供了大量的疾病靶点和相应的治疗干预措施。展望未来,现有的管理策略应该完善,临床研究应该有效地利用强有力的实验证据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Annals of Gastroenterology
Annals of Gastroenterology GASTROENTEROLOGY & HEPATOLOGY-
CiteScore
4.30
自引率
0.00%
发文量
58
期刊最新文献
Authors' reply. Clinical features and outcomes of total pancreatic lipomatosis with chronic pancreatitis: a case series. Endoscopic management of ileal pouch-anal anastomosis strictures: meta-analysis and systematic literature review. Gastrointestinal cancer incidence after lung transplantation in sarcoidosis patients. Landscape of B lymphocytes and plasma cells in digestive tract carcinomas.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1